1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA IFNLR1 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA HDHD2 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA PPM1K CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA IRF4 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA FAM89B CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA LILRB1 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA TEAD2 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA MS4A1 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA SPDYE3 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA MYBPC2 CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV